...
首页> 外文期刊>BMC Medical Imaging >Unexpected radiation pneumonitis after SIRT with significant decrease in DLCO with internal radiation exposure: a case report
【24h】

Unexpected radiation pneumonitis after SIRT with significant decrease in DLCO with internal radiation exposure: a case report

机译:患者后意外的辐射肺炎,内部辐射曝光的DLCO显着降低:案例报告

获取原文

摘要

In the last years, Selective Internal Radiation Therapy (SIRT), using biocompatible Yttrium-90 (90Y) labeled microspheres have emerged for the treatment of malignant hepatic tumors. Unfortunately, a significant part of 90Y-labeled microspheres may shunt to the lungs after intraarterial injection. It can be predictable by infusing technetium-99?m-labeled macro-aggregated albumin particles through a catheter placed in the proper hepatic artery depending on the lobe to be treated with performing a quantitative lung scintigraphy. Radiation pneumonitis (RP) can occur 1 to 6?months after the therapy, which is a rare but severe complication of SIRT. Prompt timing of steroid treatment is important due to its high mortality rate. On the other hand, pulmonary diffusion capacity measured by carbon monoxide (DLCO) is an excellent way to measure the diffusing capacity because carbon monoxide is present in minimal amount in venous blood and binds to hemoglobin in the same manner as oxygen. Some authors reported that the most consistent changes after radiation therapy (RT) are recorded with this quantitative reproducible test. The relationship between the proportional reductions in DLCO and the severity of RP developing after this therapy may prove to be clinically significant. We herein present a patient who developed RP after SIRT that could be quantified using DLCO. To the best of our knowledge, this case is the first who developed unexpected RP after SIRT with significant decrease in DLCO with internal radiation exposure. RP is a very rare complication and may lead to a fatal outcome. Decline in DLCO could be a valuable parameter for follow-up and to identify potential candidates for RP and could be also another trigger for administration of steroid therapy with prompt timing in this patient group.
机译:在过去的几年中,使用生物相容性Yttrium-90(90Y)标记的微球的选择性内部放射治疗(SIRT)用于治疗恶性肝脏肿瘤。不幸的是,90Y标记的微球的重要部分可能在眼睑射流后分流到肺部。通过在适当的肝动脉中排入到适当的肝动脉中的导管,可以预测可预测的是,根据待处理的肺刺塞。辐射肺炎(RP)可以发生1至6个?治疗后的月份,这是一种罕见但严重的温泉并发症。由于其高死亡率,因此类固醇治疗的迅速定时很重要。另一方面,通过一氧化碳(DLCO)测量的肺部扩散能力是测量漫射能力的优异方法,因为一氧化碳以静脉血液中的最小量存在,并且以与氧气相同的方式结合血红蛋白。一些作者报告说,通过这种定量可重复测试记录放射治疗(RT)后最一致的变化。 D1Co比例减少与rp开发的比例减少在该治疗后的严重程度可能证明是临床显着性。在本文中,我们在使用DLCO可以量化的速度之后开发RP的患者。据我们所知,这种情况是第一个开发出意外RP的人,其中在带有内部辐射暴露的DLCO中显着降低。 RP是一种非常罕见的并发症,可能导致致命结果。 DLCO的下降可能是用于随访的有价值的参数,并识别RP的潜在候选人,并且可以是在该患者组中迅速定时施用类固醇治疗的另一个触发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号